Atria Wealth Solutions Inc. Has $1.28 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Atria Wealth Solutions Inc. boosted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 28.6% in the fourth quarter, Holdings Channel reports. The institutional investor owned 4,256 shares of the company’s stock after acquiring an additional 946 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in HCA Healthcare were worth $1,277,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the company. MML Investors Services LLC boosted its holdings in HCA Healthcare by 31.7% in the third quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock worth $7,241,000 after purchasing an additional 4,285 shares in the last quarter. Meritage Group LP bought a new stake in shares of HCA Healthcare in the 3rd quarter worth approximately $150,548,000. Galvin Gaustad & Stein LLC acquired a new position in shares of HCA Healthcare in the 4th quarter valued at $18,044,000. Alpha DNA Investment Management LLC acquired a new stake in shares of HCA Healthcare during the 3rd quarter valued at about $869,000. Finally, NRI Wealth Management LC bought a new position in HCA Healthcare during the fourth quarter worth about $2,896,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

HCA has been the subject of several analyst reports. Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Bank of America lowered their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. Wells Fargo & Company lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their price target for the company from $400.00 to $320.00 in a research report on Monday, November 25th. Cantor Fitzgerald reissued an “overweight” rating and issued a $405.00 target price on shares of HCA Healthcare in a report on Monday, January 27th. Finally, KeyCorp cut their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Trading Down 1.7 %

HCA opened at $316.07 on Monday. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The company has a market cap of $78.49 billion, a price-to-earnings ratio of 14.39, a price-to-earnings-growth ratio of 1.10 and a beta of 1.64. The firm has a 50 day simple moving average of $313.53 and a 200 day simple moving average of $350.82.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the company earned $5.90 earnings per share. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a yield of 0.91%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s payout ratio is presently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.